<?xml version="1.0" encoding="UTF-8" ?>

    <journal>
    <language>en</language>
    <journal_id_issn>2008-2835</journal_id_issn>
    <journal_id_issn_online>2008-4625</journal_id_issn_online>
    <journal_id_pii></journal_id_pii>
    <journal_id_doi></journal_id_doi>
    <journal_id_isnet></journal_id_isnet>
    <journal_id_iranmedex>276</journal_id_iranmedex>
    <journal_id_magiran>5669</journal_id_magiran>
    <journal_id_sid>11181</journal_id_sid>
    <pubdate>
	    <type>gregorian</type>
	    <year>>2023</year>
	    <month>>April-June</month>
	    <day></day>
    </pubdate>
    <volume>15</volume>
    <number>2</number>
    <publish_type>online</publish_type>
    <publish_edition>1</publish_edition>
    <article_type>fulltext</article_type>
    <articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>37034895</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Human T2R38 Bitter Taste Receptor Expression and COVID-19: From Immunity to Prognosis</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Background: &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Bitter taste-sensing type 2 receptor (T2Rs or TAS2Rs) found on ciliated epithelial cells and solitary chemosensory cells have a role in respiratory tract immunity. T2Rs have shown protection against SARS-CoV-2 by enhancing the innate immune response. The purpose of this review is to outline the current sphere of knowledge regarding this association. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Methods: &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;A narrative review of the literature was done by searching (T2R38 OR bitter taste receptor) AND (COVID-19 OR SARS-CoV-2) keywords in PubMed and google scholar.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Results: &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;T2R38, an isoform of T2Rs encoded by the &lt;em&gt;TAS2R38 &lt;/em&gt;gene, may have a potential association between phenotypic expression of T2R38 and prognosis of COVID-19. Current studies suggest that due to different genotypes and widespread distributions of T2Rs within the respiratory tract and their role in innate immunity, treatment protocols for COVID-19 and other respiratory diseases may change accordingly. Based on the phenotypic expression of T2R38, it varies in innate immunity and host response to respiratory infection, systemic symptoms and hospitalization. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Conclusion: &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;This review reveals that patients&amp;rsquo; innate immune response to SARS-COV-2 could be influenced by T2R38 receptor allelic variations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Bitter taste receptors (T2Rs), Coronavirus disease, COVID-19, Infection, T2R38</keyword>
	<start_page>118</start_page>
	<end_page>123</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=60538</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/60538.pdf</pdf_url>
	<author_list><author><first_name>Lakshmi</first_name><middle_name></middle_name><last_name>Deepak Bethineedi </last_name><suffix></suffix><affiliation>Andhra Medical College, Visakhapatnam, Andhra Pradesh, India</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>92022</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Hediyeh</first_name><middle_name></middle_name><last_name>Baghsheikhi </last_name><suffix></suffix><affiliation>USERN Office, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>92016</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Afsaneh</first_name><middle_name></middle_name><last_name>Soltani </last_name><suffix></suffix><affiliation>USERN Office, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>92017</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Zahedeh</first_name><middle_name></middle_name><last_name>Mafi </last_name><suffix></suffix><affiliation>USERN Office, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>92018</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Noosha</first_name><middle_name></middle_name><last_name>Samieefar</last_name><suffix></suffix><affiliation>USERN Office, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>92019</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Shaikh Sanjid</first_name><middle_name></middle_name><last_name>Seraj </last_name><suffix></suffix><affiliation>Walsall Healthcare NHS Trust, Walsall Manor Hospital, Walsall, United Kingdom</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>92020</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mohammad Amin</first_name><middle_name></middle_name><last_name>Khazeei Tabari </last_name><suffix></suffix><affiliation>USERN Office, Mazandaran University of Medical Sciences, Sari, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>92021</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

